261 related articles for article (PubMed ID: 31136575)
1. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
Mekonnen B; Mihret A; Getahun M; Hailu T; Sidiki S; V Kelley H; Scordo JM; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Evans CA; Aseffa A; Torrelles JB; Wang SH; Abebe T
PLoS One; 2019; 14(5):e0215679. PubMed ID: 31136575
[TBL] [Abstract][Full Text] [Related]
2. MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Shibabaw A; Gelaw B; Kelley HV; Tesfaye E; Balada-Llasat JM; Evans CA; Torrelles JB; Wang SH; Tessema B
Int J Infect Dis; 2020 Jan; 90():213-218. PubMed ID: 31689528
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
[TBL] [Abstract][Full Text] [Related]
6. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
[TBL] [Abstract][Full Text] [Related]
8. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
[TBL] [Abstract][Full Text] [Related]
9. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
Lazarus RP; Kalaiselvan S; John KR; Michael JS
Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
Hundie GB; Woldemeskel D; Gessesse A
PLoS One; 2016; 11(12):e0169188. PubMed ID: 28030634
[TBL] [Abstract][Full Text] [Related]
12. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
[TBL] [Abstract][Full Text] [Related]
14. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
[TBL] [Abstract][Full Text] [Related]
15. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
19. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
Pandey P; Pant ND; Rijal KR; Shrestha B; Kattel S; Banjara MR; Maharjan B; Kc R
PLoS One; 2017; 12(1):e0169798. PubMed ID: 28081227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
